Related Experiment Videos
Mucosal immunodeficiency in HIV/SIV infection
M Zeitz1, R Ullrich, T Schneider
1Internal Medicine II, University of the Saarland, Homburg/Saar, Germany. inmzei@med-rz.uni-sb.de
Summary
HIV infection severely impacts the gut's immune defenses, causing significant CD4+ T cell loss in the intestinal lining. This immune disruption contributes to increased infections and malignancies in the gastrointestinal tract.
Area of Science:
- Immunology
- Gastroenterology
- Virology
Background:
- The gastrointestinal tract is vulnerable to secondary infections and malignancies in HIV infection.
- HIV disrupts local immunologic defense mechanisms within the gut.
- Studies show greater CD4+ T cell loss in the intestinal mucosa than peripheral blood in HIV patients.
Purpose of the Study:
- To investigate the impact of HIV/SIV infection on mucosal immunity in the gastrointestinal tract.
- To understand the mechanisms behind increased susceptibility to infections and malignancies in the gut during HIV/SIV infection.
Main Methods:
- Immunohistology and flow cytometry were used to analyze immune cell populations.
- Studies were conducted in both HIV-infected humans and SIV-infected nonhuman primates.
Main Results:
- A pronounced loss of CD4+ T cells was observed in the intestinal mucosa compared to peripheral blood.
- Activated CD8+ T cells increased in the intestinal lamina propria.
- Early CD4+ T cell loss in the gut mucosa was noted as early as 2 weeks post-SIV infection in primates.
Conclusions:
- Depletion and functional impairment of mucosal CD4+ T lymphocytes contribute to the breakdown of the gut immune barrier.
- This compromised barrier increases susceptibility to opportunistic and non-opportunistic infections and secondary malignancies.
- Alterations in the gut immune system may also lead to small intestinal mucosal atrophy and enterocyte maturational defects in HIV patients.